Literature DB >> 31521393

A single center study of protective and susceptible HLA alleles and haplotypes with end-stage renal disease in China.

Qinqin Pan1, Xiao Ma1, Hao Chen2, Su Fan1, Xiaoyan Wang1, Yajie You1, Zijie Wang2, Li Sun2, Xing Zhao1, Jie Shen3, Ruoyun Tan2, Guangming Gong4, Min Gu5.   

Abstract

Chronic kidney disease (CKD) is becoming a global public health problem and usually cause End-Stage Renal Disease (ESRD) in the end of progression. To analyze the associations of HLA-A, -B, -C, -DRB1 and -DQB1 alleles at high resolution with ESRD in Jiangsu province of China, a total of 499 unrelated patients with ESRD from the First Affiliated Hospital with Nanjing Medical University and 1584 healthy controls from Jiangsu Branch of Chinese Marrow Donor Program (CMDP) were genotyped at HLA-A, -B, -C, -DRB1 and -DQB1 loci. Statistical analysis was applied to compare the differences of HLA allele frequencies between patients with ESRD and healthy controls. As results, no protective allele at A locus was found and the susceptible alleles were A*11:01 and A*31:01. At B locus, B*15:01, B*55:02 and B*39:05 emerged as susceptible alleles, whereas no protective allele was found. At C locus, C*06:02 and C*07:01 emerged as protective alleles and no susceptible allele was found. At DRB1 locus, six alleles including DRB1*03:01, DRB1*04:03, DRB1*04:04, DRB1*04:05, DRB1*11:01 and DRB1*12:02 emerged as susceptible alleles, while DRB1*15:01 emerged as a protective allele. At DQB1 locus, DQB1*02:01, DQB1*03:01, DQB1*03:02 and DQB1*04:01 emerged as susceptible alleles, while DQB1*06:02 and DQB1*06:09 emerged as protective alleles. Haplotype A*11:01-C*03:03-B*15:01-DRB1*11:01-DQB1*03:01 containing four susceptible alleles was regarded as the most susceptible haplotype. The susceptible alleles and haplotypes might be used as some important risk classification markers. Besides, in the consanguineous renal transplantation, it would be very beneficial for the long-term survival of renal transplant patients to avoid the susceptible alleles and haplotypes in selecting optimal donors.
Copyright © 2019 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allele; ESRD; HLA; Haplotype

Mesh:

Substances:

Year:  2019        PMID: 31521393     DOI: 10.1016/j.humimm.2019.09.001

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  5 in total

1.  Evaluation of Human Leukocyte Antigen Class I and Class II in End-Stage Renal Disease Occurrence in Indonesian Transplantation Patients.

Authors:  Hani Susianti; Dwi Priyadi Djatmiko; I Komang Adi Widana; Deasy Ayuningtyas Tandio; Catur Suci Sutrisnani; Singgih Pudjo Wahono; Ira Puspitawati
Journal:  Int J Nephrol       Date:  2021-10-11

2.  Association of end-stage renal disease with HLA phenotypes and panel reactive antibodies in patients awaiting renal transplantation in Hunan Province.

Authors:  Lu Long; Qian Sun
Journal:  J Clin Lab Anal       Date:  2022-01-26       Impact factor: 2.352

3.  Association between HLA alleles and sub-phenotype of childhood steroid-sensitive nephrotic syndrome.

Authors:  Hao Lee; Li Wang; Fen-Fen Ni; Xue-Ying Yang; Shi-Pin Feng; Xiao-Jie Gao; Huan Chi; Ye-Tao Luo; Xue-Lan Chen; Bao-Hui Yang; Jun-Li Wan; Jia Jiao; Dao-Qi Wu; Gao-Fu Zhang; Mo Wang; Hai-Ping Yang; Han Chan; Qiu Li
Journal:  World J Pediatr       Date:  2022-01-01       Impact factor: 2.764

Review 4.  Evolution and molecular interactions of major histocompatibility complex (MHC)-G, -E and -F genes.

Authors:  Antonio Arnaiz-Villena; Fabio Suarez-Trujillo; Ignacio Juarez; Carmen Rodríguez-Sainz; José Palacio-Gruber; Christian Vaquero-Yuste; Marta Molina-Alejandre; Eduardo Fernández-Cruz; José Manuel Martin-Villa
Journal:  Cell Mol Life Sci       Date:  2022-08-04       Impact factor: 9.207

Review 5.  Systematic review of associations between HLA and renal function.

Authors:  Marcus Lowe; Steven Jervis; Antony Payton; Kay Poulton; Judith Worthington; Isla Gemmell; Arpana Verma
Journal:  Int J Immunogenet       Date:  2021-12-17       Impact factor: 2.385

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.